MICA and neoplasm: In part, these miRNAs were shown to be overexpressed in the tumor itself (“oncomiRs”), like miR-93 that targets both MICA and MICB, but also in metastasis-associated miRNAs (“metastamiRs”), like miR-10b, that targets MICB expression (21).